Shenzhen Zhijun Medical & Pharmaceutical Trading Co., Ltd.

Shenzhen Zhijun Pharmaceutical. Co. Ltd was established in 1985, formerly known as Shenzhen Pharmaceutical Factory, has always been the key role in the cephalosporin manufacturing lineup of SINOPHARM group and the core manufacturing enterprise in SINOPHARM Accord.
 

With more than 20 years of endeavor, Zhijun has grown up into a national High-Tech Enterprise and is listed Top 50 Pharmaceuticals in China. Aiming at one target, the 1200 staffs of Zhijun focus on the development of Quality, Efficiency, Technology. Till now, Zhijun has a total assets of more than RMB1000 million, with annual turnover of RMB1,600 million, annual total profit RMB 200 million and annual tax-paying over RMB 150 million. 
 

Zhijun is mainly focusing on anti-infective, respiratory, digestive remedies and healthcare products. Based on an international standardized R&D and production premise of 42,000 square kilometers, there are totally 10 production lines within 6 workshops, which are powder for injection, oral solution and oral solid (for cephalosporin and non-cephalosporin). What’s more, both cephalosporin injectable and oral solid facilities have got the EU GMP approval. A series of market leading products have established by Zhijun with stringent quality control and management system and powerful marketing network. Dalixin (Cefuroxime injectable and oral solution) and Dalifen (Cefixime oral solution) are the best player, leading the Dali brand and Zhijun brand to the top of the marketplace. Meanwhile, the company is expanding the business in overseas markets and building strong reputation profile in global marketplace step by step. 
 

In future, by integrating R&D and marketing and devoting into technology innovation, Zhijun will concentrate on anti-infective, respiratory system, digestive system, cardiovascular, OTC and healthcare products. With excellent quality and core competitive advantages, Zhijun aims to become a brand provider of pharmaceutical products and healthcare service in both domestic and international market.